摘要
最近,纳米粒子使针对细胞组织的治疗药物的靶向给药成为可能,这对基础生物科学,制药工业,临床前医学和转化医学造成了重大影响。这些材料的对药代动力学,生物分布和治疗分子的长期活动进行改造以适应特殊疾病和避免不良反应的能力是很有前途的。但是来自体循环的靶向纳米粒子的治疗效率很低,而且我们对体内活动的基本过程的传导了解有限。因此,我们很难作出这些材料的最佳合理设计以期达到最大效能。最近,多模式和多尺度成像技术的兴起有助于我们对这些过程的进一步认识。治疗诊断成像剂能给出实时的量化的药物分布和治疗反应的显示值,多模式成像平台可以进行从细胞到组织水平的分布的多尺度分析,而且令人振奋的是,在活体组织镜检中应用提供了细胞水平上的关键认识。在这篇综述中,我们讲述了多尺度成像如何使我们能够完善纳米药物,并且讨论了进一步促进其临床转化的未来方向。
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
Current Drug Targets
Title:Multiscale Imaging of Nanoparticle Drug Delivery
Volume: 16 Issue: 6
Author(s): Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith
Affiliation:
关键词: 增强的通透性和保留,荧光,活体镜检,核磁共振成像,纳米材料,纳米药物,纳米技术,正电子发射体层摄影,量子点。
摘要: Nanoparticles have recently had a major impact on basic biosciences, the pharmaceutical industry, and preclinical and translational medicine by enabling targeted delivery of therapeutic cargo to cells and tissues. The capacity to specifically tailor the pharmacokinetics, biodistribution, and longterm fate of therapeutic molecules for specific diseases and to avoid off-target side effects is a tremendously promising capability of these materials. However targeting of nanoparticle therapies from systemic circulation is very inefficient, and our understanding of the fundamental processes dictating in vivo fate remains limited, making it challenging to determine how to optimally and rationally design these materials for maximum efficacy. Recently multi-modal, multi-scale imaging technologies have emerged that have helped to improve our insight into these processes. Theranostic imaging agents have provided real-time and quantitative readouts of drug distribution and therapeutic response, multimodal imaging platforms have allowed a multi-scale analysis of distribution from the levels of cells to tissues, and exciting applications in live-animal tissue microscopy have provided key insights at the cellular level. In this review, we describe how multiscale imaging has shaped our ability to optimize nanoparticle drugs and discuss future directions that are expected to further catalyze clinical translation.
Export Options
About this article
Cite this article as:
Lawrence W. Dobrucki, Dipanjan Pan and Andrew M. Smith , Multiscale Imaging of Nanoparticle Drug Delivery, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450116666150202163022
DOI https://dx.doi.org/10.2174/1389450116666150202163022 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease
Current Medicinal Chemistry Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Refined Echocardiographic Assessment and Contemporary Medical Treatment of Obstructive Hypertrophic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Neuroprotective Agents
Current Medicinal Chemistry Hymenoptera Venom Allergy and Anaphylaxis
Current Pharmaceutical Design LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy
Current Cancer Drug Targets The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery The Tree of Sirtuins and the Garden of Cardiovascular Youth
Current Vascular Pharmacology Anesthetic and Adjunctive Drugs for Fast-Track Surgery
Current Drug Targets Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Preface
Recent Patents on Medical Imaging Radial Distribution of Elasticity in Porcine Thoracic Aorta
Vascular Disease Prevention (Discontinued) Lipoprotein(a) as a Predictive Biomarker and Therapeutic Target for Acute Coronary Syndromes
Current Pharmaceutical Design Intrahepatic Pseudoaneurysm Developing at the Confluence of Bilateral Biliary Drains Six Months Following a Procedure- A Case Report
Current Medical Imaging Congenital Heart Disease in Non-Diabetic Large-for-Gestational-Age (LGA) Neonates
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical Applications
Current Pharmaceutical Design Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis
Current Cardiology Reviews Current Understanding of the Molecular Mechanism between Hemodynamic- Induced Intracranial Aneurysm and Inflammation
Current Protein & Peptide Science